Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study-Reference-Cited by-同舟云学术

Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study

Published:2023-04 Issue: Volume:Volume 16 Page:2271-2279
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Zou Xuehan^ORCID,Jin Shaojun,Chen Lingxia,Li Jie,Zhang Xiaofan,Zhou Hua^ORCID,Li Xi^ORCID,Huang Haijun

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference40 articles.

1. World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. World Health Organization; 2017; Available from: http://www.who.int/medicines/areas/rational_use/prioritization-of-pathogens/en/. Accessed March 28, 2023.

2. Phenotypic and Genotypic Characterization of Carbapenem-resistantEnterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012–2016)

3. The structure of β-lactamases

4. Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential;Biomolecules;2024-06-30

2. Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications;Expert Review of Anti-infective Therapy;2024-05-08

3. Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections;Frontiers in Microbiology;2024-04-05

4. In Vitro Activity of Eravacycline against Carbapenemase-Producing Gram-Negative Bacilli Clinical Isolates in Central Poland;Biomedicines;2023-06-21